We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Palomar
PLMR
$3.61B
| $61K | 0.01% |
+682
| New | +$57.4K |
|
377
StoneX
SNEX
$9.1B
| $61K | 0.01% |
+5,300
| New | +$59.9K |
|
378
WisdomTree
WT
$3.42B
| $61K | 0.01% |
+11,480
| New | +$49.4K |
|
|
HA
379
DELISTED
Hawaiian Holdings, Inc.
HA
| $61K | 0.01% |
+3,433
| New | +$58.1K |
|
380
Bio-Rad Laboratories Class A
BIO
$8.91B
| $60K | ﹤0.01% |
+103
| New | +$58.7K |
|
381
Masco
MAS
$15.2B
| $60K | ﹤0.01% |
+1,087
| New | +$59.9K |
|
382
Whirlpool
WHR
$2.89B
| $60K | ﹤0.01% |
+330
| New | +$63.2K |
|
383
Alarm.com
ALRM
$2.76B
| $59K | ﹤0.01% |
+566
| New | +$41.1K |
|
384
Strategy Inc
MSTR
$35.7B
| $59K | ﹤0.01% |
+1,530
| New | +$35.7K |
|
385
Danaher
DHR
$137B
| $58K | ﹤0.01% |
+296
| New | +$59.3K |
|
|
HOLX
386
DELISTED
Hologic
HOLX
| $58K | ﹤0.01% |
+801
| New | +$56.5K |
|
387
Micron Technology
MU
$1.01T
| $58K | ﹤0.01% |
+778
| New | +$46.9K |
|
388
Virtus Investment Partners
VRTS
$1.11B
| $58K | ﹤0.01% |
+269
| New | +$48.9K |
|
|
NLSN
389
DELISTED
Nielsen Holdings plc
NLSN
| $58K | ﹤0.01% |
+2,793
| New | +$45.3K |
|
390
A.O. Smith
AOS
$8.61B
| $57K | ﹤0.01% |
+1,047
| New | +$57.7K |
|
391
DXC Technology
DXC
$1.76B
| $57K | ﹤0.01% |
+2,207
| New | +$47.1K |
|
392
Trupanion
TRUP
$1.08B
| $57K | ﹤0.01% |
+480
| New | +$45.3K |
|
|
AAMI
393
Acadian Asset Management
AAMI
$3.28B
| $57K | ﹤0.01% |
+2,943
| New | +$49.5K |
|
|
WDR
394
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $57K | ﹤0.01% |
+2,243
| New | +$43.2K |
|
395
Accenture
ACN
$104B
| $56K | ﹤0.01% |
+213
| New | +$51.1K |
|
|
BNY
396
Bank of New York Mellon
BNY
$106B
| $56K | ﹤0.01% |
+1,322
| New | +$50.8K |
|
397
DaVita
DVA
$14.6B
| $56K | ﹤0.01% |
+480
| New | +$48.9K |
|
398
Hilton Worldwide
HLT
$70.2B
| $56K | ﹤0.01% |
+502
| New | +$49.7K |
|
399
Las Vegas Sands
LVS
$29.8B
| $56K | ﹤0.01% |
+934
| New | +$49.8K |
|
400
Pool Corp
POOL
$7.39B
| $56K | ﹤0.01% |
+150
| New | +$52.3K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.